Key Insights

Highlights

Success Rate

90% trial completion (above average)

Published Results

34 trials with published results (23%)

Research Maturity

98 completed trials (67% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

7.5%

11 terminated out of 146 trials

Success Rate

89.9%

+3.4% vs benchmark

Late-Stage Pipeline

36%

53 trials in Phase 3/4

Results Transparency

35%

34 of 98 completed with results

Key Signals

34 with results90% success11 terminated

Data Visualizations

Phase Distribution

92Total
Not Applicable (18)
P 1 (4)
P 2 (17)
P 3 (30)
P 4 (23)

Trial Status

Completed98
Unknown20
Terminated11
Recruiting10
Active Not Recruiting3
Withdrawn2

Trial Success Rate

89.9%

Benchmark: 86.5%

Based on 98 completed trials

Clinical Trials (146)

Showing 20 of 20 trials
NCT05301348Not ApplicableRecruitingPrimary

In Vivo Detection of Circulating Clots in Patients With Thromboembolism

NCT04258488Phase 4Recruiting

Long-term Anticoagulation With Oral Factor Xa Inhibitor Versus Vitamin K Antagonist After Mechanical Aortic Valve Replacement

NCT05643885CompletedPrimary

A Study to Compare Health Care Costs Between Apixaban and Low Molecular Weight Heparin in Patients With Venous Thromboembolism and Cancer

NCT06118957Phase 2CompletedPrimary

Low Molecular Weight Heparin or no Treatment Following Cesarean Delivery

NCT05625932Phase 3Completed

TINzaparin Prophylaxis in Patients With Metastatic Colorectal Cancer

NCT07095634Enrolling By Invitation

Estimation of Cardiovascular Risk in Patients With Crohn's Disease and Ulcerative Colitis (PROVACI)

NCT06062329Not ApplicableCompleted

SYMPHONY-PE Study for Treatment of Pulmonary Embolism

NCT04997265Not ApplicableCompleted

Strategies for Anticoagulation During Venovenous ECMO

NCT05796557Phase 4Completed

ECMO Hemostatic Transfusions in Children

NCT03855592RecruitingPrimary

Registry of Thrombosis & NEoplasia of "Sociedad Española de Oncología Médica"

NCT05794165Phase 2Enrolling By Invitation

Antithrombin to Improve Thromboprophylaxis and Reduce the Incidence of Trauma-Related Venous Thromboembolism

NCT06657924Phase 2Recruiting

Preoperative Tranexamic Acid (TXA) to Prevent Bleeding in Patients Undergoing Major Colorectal Surgery

NCT05313620Phase 4Recruiting

Effect of Tofacitinib on Coagulation and Platelet Function, and Its Role in Thromboembolic Events

NCT00967447TerminatedPrimary

Study to Evaluate the Safety and Efficacy of Pradaxar for the Prevention of Venous Thromboembolism in the Mexican Population Undergoing Elective Total Hip or Knee Replacement Surgery

NCT03877770CompletedPrimary

DVT After Cardiac Procedure

NCT06806540RecruitingPrimary

The Frequency of Peripheral Arterial Disease in Patients with Deep Vein Thrombosis of the Lower Limbs

NCT05548010CompletedPrimary

Venous Thromboembolism (VTE) Knowledge

NCT06442267Phase 4Recruiting

Comparing Anticoagulation Strategies Using UFH, Argatroban and LMWH for ECMO Support

NCT05575466Completed

Thromboembolism in Anorexia Nervosa

NCT06627933RecruitingPrimary

Optimization of Management in Patients With Cardiovascular Disease After Lower Limb Joint Replacement

Scroll to load more

Research Network

Activity Timeline